Table 2.

Mutation status of the 64 patients with papillary thyroid carcinoma in the study population

Mutation types	No. (%)
BRAF mutation
Absent	31 (48.4%)
Present	33 (51.6%)
RAS mutation
Absent	62 (96.9%)
Present	2 (3.1%)
RET rearrangements
Absent	55 (85.9%)
Present	9 (14.1%)